Egg Freezing and Embryo Banking Global Market Report 2024

The egg freezing and embryo banking market size has grown rapidly in recent years. It will grow from $3.43 billion in 2023 to $3.91 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth during the historic period can be attributed to rising fertility issues, expanding insurance coverage, increasing demand for donor eggs, and the emergence of social egg freezing parties.

The egg freezing and embryo banking market size is expected to see rapid growth in the next few years. It will grow to $6.6 billion in 2028 at a compound annual growth rate (CAGR) of 14%. The growth in the forecast period can be attributed to the rise of social freezing, increasing research and development efforts, the adoption of preimplantation genetic testing, expanding educational initiatives, and a rising number of women seeking IVF services. Major trends expected during the forecast period include product innovations, partnerships, and continued research and development efforts.

The increasing popularity of social freezing is anticipated to drive the growth of both the egg-freezing and embryo banking markets in the future. Social freezing involves women undergoing ovarian stimulation, egg retrieval, and freezing of their eggs for non-medical purposes. This trend has emerged due to individuals' desire to preserve their fertility for various reasons such as career advancement, pursuing education, lack of a partner, or achieving financial stability. Egg freezing and embryo banking serve as essential components of social freezing, providing individuals with the opportunity to preserve their fertility and reproductive options for non-medical reasons, empowering them to make informed decisions about family planning according to their own timelines. For example, as reported in April 2024 by the American Society for Reproductive Medicine, preliminary national data for 2021 showed a significant surge in egg-freezing cycles reported by SART-member clinics, increasing by over 31% compared to the previous year, from 16,786 to 24,558. This substantial rise underscores the increasing demand for fertility preservation treatments, driven by the rise of social freezing.

Key players in the egg-freezing and embryo banking markets are dedicated to developing innovative fertility preservation solutions, including comprehensive fertility preservation banks. These banks provide frozen donor eggs to intended parents as an alternative to using fresh eggs. For instance, in March 2023, Pinnacle Fertility, a US-based fertility services provider, introduced the Pinnacle Egg Bank, aiming to broaden access to egg donor options nationwide. This solution offers features such as access to high-quality frozen donor eggs, rigorous screening of egg donors, expertise in egg donation and cryopreservation, a seamless patient journey, and success rates comparable to those achieved with fresh eggs.

In June 2023, Pinnacle Fertility partnered with TMRW Life Sciences to implement cutting-edge technology for the safe management and storage of frozen eggs and embryos. This collaboration aims to elevate the standard of care across Pinnacle's network clinics and improve safety, accuracy, efficiency, and transparency in specimen management through the adoption of TMRW Life Sciences' automated platform for egg freezing and embryo banking. TMRW Life Sciences is a US-based company specializing in automated solutions for reproductive specimen management.

Major companies operating in the egg freezing and embryo banking market are Mayo Clinic, Cleveland Clinic Fertility Center, The Cooper Companies Inc., Reproductive Medicine Associates Network LLC, Shady Grove Fertility, Virtus Health Limited, Monash IVF Group Limited, Kindbody Inc., Carrot Fertility Inc., CREATE Fertility Limited, New England Cryogenic Center Inc., CCRM Management Company LLC, Reproductive Biology Associates LLC, Genea Limited, WINFertility Inc., California Cryobank Inc., Fairfax Cryobank Inc., Institut Marquès, Extend Fertility Medical Practice PLLC, The London Women’s Clinic Limited, Kitazato Corporation, ReproTech LLC, IVF Australia, CHA Medical Group Inc., West Coast Fertility Centers Inc.

Europe was the largest region in the egg freezing and embryo banking market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the egg freezing and embryo banking market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the egg freezing and embryo banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Egg freezing and embryo banking are assisted reproductive technologies that enable individuals to preserve their fertility for future use. These methods are beneficial for individuals who wish to maintain their fertility at their current age and pursue parenthood when they are ready.

The primary types of egg freezing and embryo banking include donor and non-donor options. Donor egg or embryo utilization involves fertility treatments where eggs or embryos are donated by another individual or couple. Both egg freezing and embryo freezing techniques can be used for preservation. These methods are commonly employed by individuals under 30 years old as well as those above 30 years old. Various end users, including fertility centers, hospitals, cryobanks, and others, apply these technologies.

The egg freezing and embryo banking market research report is one of a series of new reports that provides egg freezing and embryo banking market statistics, including egg freezing and embryo banking industry global market size, regional shares, competitors with an egg freezing and embryo banking market share, detailed egg freezing and embryo banking market segments, market trends and opportunities, and any further data you may need to thrive in the egg freezing and embryo banking industry. This egg freezing and embryo banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The egg freezing and embryo banking market includes revenues earned by entities through services such as ovarian stimulation, egg retrieval, in vitro fertilization, embryo selection, and embryo thawing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.